Cuilin Zhang1, Mary L Hediger1, Paul S Albert2, Jagteshwar Grewal1, Anthony Sciscione3, William A Grobman4, Deborah A Wing5,6, Roger B Newman7, Ronald Wapner8, Mary E D'Alton8, Daniel Skupski9, Michael P Nageotte10, Angela C Ranzini11, John Owen12, Edward K Chien13, Sabrina Craigo14, Sungduk Kim2, Katherine L Grantz1, Germaine M Buck Louis1. 1. Division of Intramural Population Health Research, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland. 2. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 3. Christiana Care Health System, Newark, Delaware. 4. Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. 5. Division of Maternal-Fetal Medicine, Department of Obstetrics-Gynecology, University of California School of Medicine, Irvine. 6. Fountain Valley Regional Hospital and Medical Center, Fountain Valley, California. 7. Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston. 8. Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York. 9. Department of Obstetrics and Gynecology, New York-Presbyterian Hospital/Queens, Queens. 10. Department of Obstetrics and Gynecology, Miller Children's Hospital/Long Beach Memorial Medical Center, Long Beach, California. 11. Division of Maternal and Fetal Medicine, Department of Obstetrics and Gynecology, St Peter's University Hospital, New Brunswick, New Jersey. 12. Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology University of Alabama School of Medicine, Birmingham. 13. Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Women and Infants Hospital of Rhode Island, Providence. 14. Department of Obstetrics and Gynecology, Tufts Medical Center, Boston, Massachusetts.
Abstract
Importance: Despite the increasing prevalence of pregravid obesity, systematic evaluation of the association of maternal obesity with fetal growth trajectories is lacking. Objective: To characterize differences in fetal growth trajectories between obese and nonobese pregnant women, and to identify the timing of any observed differences. Design, Setting, and Participants: The Eunice Kennedy Shriver National Institute of Child Health and Human Development Fetal Growth Studies-Singletons study enrolled cohorts of pregnant women at 12 US health care institutions. Obese women (with prepregnancy body mass index > 30) and nonobese women (prepregnancy body mass indexes, 19-29.9) without major chronic diseases were recruited between 8 weeks and 0 days' gestation and 13 weeks and 6 days' gestation. A mixed longitudinal randomization scheme randomized participants into 1 of 4 schedules for 2-dimensional and 3-dimensional ultrasonograms to capture weekly fetal growth data throughout the remainder of their pregnancies. Main Outcomes and Measures: On each ultrasonogram, fetal humerus length, femur length, biparietal diameter, head circumference, and abdominal circumference were measured. Fetal growth curves were estimated using linear mixed models with cubic splines. Median differences in the fetal measures at each gestational week of the obese and nonobese participants were examined using the likelihood ratio and Wald tests after adjustment for maternal characteristics. Results: The study enrolled 468 obese and 2334 nonobese women between 8 weeks and 0 days' gestation and 13 weeks and 6 days' gestation. After a priori exclusion criteria, 443 obese and 2320 nonobese women composed the final cohort. Commencing at 21 weeks' gestation, femur length and humerus length were significantly longer for fetuses of obese woman than those of nonobese women. Differences persisted in obese and nonobese groups through 38 weeks' gestation (median femur length, 71.0 vs 70.2 mm; P = .01; median humerus length, 62.2 vs 61.6 mm; P = .03). Averaged across gestation, head circumference was significantly larger in fetuses of obese women than those of nonobese women (P = .02). Fetal abdominal circumference was not greater in the obese cohort than in the nonobese cohort but was significantly larger than in fetuses of normal-weight women (with body mass indexes between 19.0-24.9) commencing at 32 weeks (median, 282.1 vs 280.2 mm; P = .04). Starting from 30 weeks' gestation, estimated fetal weight was significantly larger for the fetuses of obese women (median, 1512 g [95% CI, 1494-1530 g] vs 1492 g [95% CI, 1484-1499 g]) and the difference grew as gestational age increased. Birth weight was higher by almost 100 g in neonates born to obese women than to nonobese women (mean, 3373.2 vs 3279.5 g). Conclusions and Relevance: As early as 32 weeks' gestation, fetuses of obese women had higher weights than fetuses of nonobese women. The mechanisms and long-term health implications of these findings are not yet established.
Importance: Despite the increasing prevalence of pregravid obesity, systematic evaluation of the association of maternal obesity with fetal growth trajectories is lacking. Objective: To characterize differences in fetal growth trajectories between obese and nonobese pregnant women, and to identify the timing of any observed differences. Design, Setting, and Participants: The Eunice Kennedy Shriver National Institute of Child Health and Human Development Fetal Growth Studies-Singletons study enrolled cohorts of pregnant women at 12 US health care institutions. Obesewomen (with prepregnancy body mass index > 30) and nonobese women (prepregnancy body mass indexes, 19-29.9) without major chronic diseases were recruited between 8 weeks and 0 days' gestation and 13 weeks and 6 days' gestation. A mixed longitudinal randomization scheme randomized participants into 1 of 4 schedules for 2-dimensional and 3-dimensional ultrasonograms to capture weekly fetal growth data throughout the remainder of their pregnancies. Main Outcomes and Measures: On each ultrasonogram, fetal humerus length, femur length, biparietal diameter, head circumference, and abdominal circumference were measured. Fetal growth curves were estimated using linear mixed models with cubic splines. Median differences in the fetal measures at each gestational week of the obese and nonobese participants were examined using the likelihood ratio and Wald tests after adjustment for maternal characteristics. Results: The study enrolled 468 obese and 2334 nonobese women between 8 weeks and 0 days' gestation and 13 weeks and 6 days' gestation. After a priori exclusion criteria, 443 obese and 2320 nonobese women composed the final cohort. Commencing at 21 weeks' gestation, femur length and humerus length were significantly longer for fetuses of obesewoman than those of nonobese women. Differences persisted in obese and nonobese groups through 38 weeks' gestation (median femur length, 71.0 vs 70.2 mm; P = .01; median humerus length, 62.2 vs 61.6 mm; P = .03). Averaged across gestation, head circumference was significantly larger in fetuses of obesewomen than those of nonobese women (P = .02). Fetal abdominal circumference was not greater in the obese cohort than in the nonobese cohort but was significantly larger than in fetuses of normal-weight women (with body mass indexes between 19.0-24.9) commencing at 32 weeks (median, 282.1 vs 280.2 mm; P = .04). Starting from 30 weeks' gestation, estimated fetal weight was significantly larger for the fetuses of obesewomen (median, 1512 g [95% CI, 1494-1530 g] vs 1492 g [95% CI, 1484-1499 g]) and the difference grew as gestational age increased. Birth weight was higher by almost 100 g in neonates born to obesewomen than to nonobese women (mean, 3373.2 vs 3279.5 g). Conclusions and Relevance: As early as 32 weeks' gestation, fetuses of obesewomen had higher weights than fetuses of nonobese women. The mechanisms and long-term health implications of these findings are not yet established.
Authors: Elaine L Duryea; Josiah S Hawkins; Donald D McIntire; Brian M Casey; Kenneth J Leveno Journal: Obstet Gynecol Date: 2014-07 Impact factor: 7.661
Authors: Frances M Stewart; Dilys J Freeman; Jane E Ramsay; Ian A Greer; Muriel Caslake; William R Ferrell Journal: J Clin Endocrinol Metab Date: 2006-12-27 Impact factor: 5.958
Authors: Katherine L Grantz; Jagteshwar Grewal; Paul S Albert; Ronald Wapner; Mary E D'Alton; Anthony Sciscione; William A Grobman; Deborah A Wing; John Owen; Roger B Newman; Edward K Chien; Robert E Gore-Langton; Sungduk Kim; Cuilin Zhang; Germaine M Buck Louis; Mary L Hediger Journal: Am J Obstet Gynecol Date: 2016-04-30 Impact factor: 8.661
Authors: Julio Mateus; Roger B Newman; Cuilin Zhang; Sarah J Pugh; Jagteshwar Grewal; Sungduk Kim; William A Grobman; John Owen; Anthony C Sciscione; Ronald J Wapner; Daniel Skupski; Edward Chien; Deborah A Wing; Angela C Ranzini; Michael P Nageotte; Nicole Gerlanc; Paul S Albert; Katherine L Grantz Journal: Am J Obstet Gynecol Date: 2019-06-19 Impact factor: 8.661
Authors: Mengying Li; Stefanie N Hinkle; Katherine L Grantz; Sungduk Kim; Jagteshwar Grewal; William A Grobman; Daniel W Skupski; Roger B Newman; Edward K Chien; Anthony Sciscione; Noelia Zork; Deborah A Wing; Michael Nageotte; Fasil Tekola-Ayele; Germaine M Buck Louis; Paul S Albert; Cuilin Zhang Journal: Lancet Diabetes Endocrinol Date: 2020-03-02 Impact factor: 32.069
Authors: Pamela L Ferguson; Sarah Commodore; Brian Neelon; JacKetta Cobbs; Anthony C Sciscione; William A Grobman; Roger B Newman; Alan T Tita; Michael P Nageotte; Kristy Palomares; Daniel W Skupski; John E Vena; Kelly J Hunt Journal: Child Adolesc Obes Date: 2022-01-13
Authors: Stefanie N Hinkle; Mengying Li; Jagteshwar Grewal; Samrawit F Yisahak; William A Grobman; Roger B Newman; Deborah A Wing; Katherine L Grantz; Cuilin Zhang Journal: J Acad Nutr Diet Date: 2021-05-19 Impact factor: 4.910
Authors: Linette van Duijn; Melek Rousian; Joop S E Laven; Régine P M Steegers-Theunissen Journal: Int J Obes (Lond) Date: 2021-07-21 Impact factor: 5.095